ANU seeks commercial partner to bid for government mRNA deal

Sally Whyte
Updated June 1 2021 - 9:14am, first published 9:00am
Professor Thomas Preiss, centre, with other RNA biologists that make up the RNA research and development hub at the John Curtin School of Medical Research. Picture: Sitthixay Ditthavong
Professor Thomas Preiss, centre, with other RNA biologists that make up the RNA research and development hub at the John Curtin School of Medical Research. Picture: Sitthixay Ditthavong

A group of researchers at the Australian National University is preparing to approach commercial outfits in the biotech industry, offering the university's RNA hub as a potential partner in bids for the government-sponsored mRNA vaccine manufacturing facility.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Sally Whyte

Sally Whyte

Federal Politics Reporter

I report on a range of issues in federal politics and the public service, with a real passion for how decisions made in Canberra affect the lives of Australians.

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.